• About us
  • People
  • Expertise
    • Sectors
        • Technology, media & communications Technology, media & communications
        • Private Wealth Private wealth
        • Real estate, infrastructure & energy
        • Life sciences & healthcare icon Life sciences & healthcare
        • Aerospace & defence
        • Automotive & mobility
        • Business & professional services
        • Chemicals
        • Consumer & retail
        • Financial institutions & insurance
        • Hotels, hospitality & leisure
        • Logistics & transport
        • Manufacturing & industrials
        • Public services & education
    • Legal services
        • Artificial intelligence
        • Banking & finance
        • Brands & advertising
        • Commercial & consumer contracts
        • Competition, EU & trade
        • Copyright & media law
        • Corporate crime & compliance
        • Corporate/M&A & capital markets
        • Data & cyber
        • Disputes & investigations
        • Employment, pensions & mobility
        • Environmental, planning & regulatory
        • Environmental, social & governance (ESG)
        • Information technology
        • Multi-service
        • Patents & innovation
        • Private client
        • Private equity
        • Projects, energy & infrastructure
        • Real estate & construction
        • Regulation
        • Restructuring & insolvency
        • Tax
        • Venture capital
  • Locations
    • Europe
        • Locations
        • Austria
        • Belgium
        • Czech Republic
        • France
        • Germany
        • Hungary
        • Italy
        • Netherlands
        • Poland
        • Portugal
        • Ireland
        • Slovakia
        • Spain
        • United Kingdom
        • Ukraine
          Groups & regions
        • CEE Turkish Desk
        • French German group
        • Our offices
    • Middle East & Africa
        • Locations
        • Middle East
        • UAE
          Groups
        • Africa group
        • Israel group
        • Our offices
    • Americas
        • Locations
        • Latin America
        • USA
          Groups
        • Brazil group
        • Our offices
    • Asia
        • Locations
        • Asia
        • China
        • South Korea
          Groups
        • India group
        • Japan group
        • Our offices
  • Insights
    • Insights
        • Featured Topics
        • Artificial intelligence
        • Data Centre Expertise
        • The EU Whistleblower Directive
        • German Supply Chain Act
        • Unified Patent Court
          Content hub
        • Global Data Hub
        • Interface: tech, IP and media law
        • Podcasts
        • Synapse
        • Browse All Insights
    • Events
        • In person
        • Online
        • Browse All Events
    • News
        • Media centre
        • Work highlights
        • Firm news
        • Browse all news
  • Careers
  • EN
    • English
    • 中文(简体)
    • Français
    • Deutsch
  • Home
  • News & insights
  • Events
  • Online
  • Joint Ventures or Ju…
coffee break
Coffee Break Life Sciences #5

Joint Ventures or Just Temporary Marriages? – How Not to Run a Business Relationship in Life Sciences

Online Online
21 May 2025

Why do so many joint ventures fall apart? During our Coffee Break, we took a light-hearted look at the most common reasons for joint venture failures — from exit strategies without real exits and deadlocked decision-making to IP battles and cultural clashes. A quick reality check for anyone considering entering a joint venture “marriage".

Our Key Takeaways

  1. Treat a JV like a marriage: Success depends on shared goals, mutual trust, clear boundaries — and a well-prepared “prenup” for when things go wrong.
  2. Plan exit routes early: JVs without clear exit mechanisms risk deadlock, frustration, or costly breakups. Build in buy-sell options, sunset clauses, and triggers from the start.
  3. Define IP ownership up front: Joint IP is a recipe for disputes unless ownership, licensing, and post-JV use rights are clearly defined.
  4. Align strategic objectives: Differing agendas — one partner chasing ROI, the other seeking tech transfer — are a common cause of JV drift. Alignment must be tested and maintained over time.
  5. Compliance is not an afterthought: In life sciences, regulatory missteps are costly. Assign responsibilities early, form joint compliance teams, and follow the strictest standards.

Access the recording

 

Expertise

Services and Groups

Joint ventures

Sectors

Life sciences & healthcare
OUR SPEAKER

Dr. Amir-Said Ghassabeh

Partner

Hamburg
Read More
Share this page
  • Share this page
Call To Action Arrow Image

Would you like to receive future invitations to our webinar series?

Sign up to mailing list
Sign up to mailing list
Subscribe to our latest insights
  • About us
  • Campaigns and online tools
  • News
  • People
  • Expertise
  • Locations
  • Insights
  • Events
  • Media centre
  • Contact
  • Careers
  • Alumni
  • Data protection & privacy policy
  • Cookie policy
  • Legal and regulatory information
  • Regulatory information on costs
  • Complaints procedure for clients
  • Terms of use
  • Anti-slavery statement
  • Environmental
  • Scam emails

© Taylor Wessing